Debbie Haynes

Debbie Haynes has a diverse and extensive work experience spanning over several prestigious companies in the pharmaceutical and medical research industries. Debbie is currently serving as the Chief Operating Officer at CellCentric since January 2022. Prior to this, they held the position of Regulatory and Strategy Director at the same company from September 2021 to January 2022.

Before joining CellCentric, Debbie had a notable tenure at Sarah Cannon Research Institute where they held various roles. Debbie was the Vice President of Clinical Development from March 2020 to September 2021 and also served as the VP of Business Innovation from November 2009 to September 2021.

Debbie also worked at Genentech as the Regional Head for Europe, Middle East, and Africa from June 2008 to October 2009, and at Johnson & Johnson as a Director of Regulatory Affairs from October 2006 to June 2008.

Debbie has contributed their expertise to Dainippon Sumitomo Pharma as the Head of Regulatory Strategy, CQA, Training & Process Improvement from August 2004 to October 2006, and held the position of Regulatory Affairs Manager at Daiichi Pharmaceuticals UK from January 2003 to August 2004.

Debbie's career began at Elan, where they served as an Associate Director from January 1997 to December 2002.

Debbie Haynes completed their education at The University of Manchester from 1990 to 1993, earning a BSc (Hons) degree in Anatomical Sciences.